Get started
Author

Jill Fulcher

Observed names: J. Fulcher, Jill Mackarel
ORCID: 0000-0002-0369-5034
Observed ORCID: 0000-0002-0369-5034
OpenAlex ID: A5057440899
Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study
2021 · Andrzej Chruscinski, Stephen Juvet, et al. · Transplantation · 25
Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies
2020 · Harinad Maganti, Alissa Visram, et al. · Leukemia Research · 24
Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial
2024 · Daniel J. DeAngelo, Jun Yin, et al. · Blood · 23
PDF
In support of upfront stem cell transplantation as first‐line therapy for paediatric patients with idiopathic severe aplastic anaemia who lack a sibling donor
2016 · Jill Mackarel, Maria Iatan, et al. · British Journal of Haematology · 19
Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario
2021 · Anne Tierens, Tracy L. Stockley, et al. · Current Oncology · 17
PDF
Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia
2021 · Jill Fulcher, Philip Berardi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia – time to reconsider current approaches?
2020 · J. Fulcher, M. Carrier · Thrombosis Research · 10
Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia
2018 · Alissa Visram, Joseph Aziz, et al. · Transplantation and Cellular Therapy · 10
Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers
2022 · Jill Fulcher, Alexandre P. Blanchard, et al. · Transplantation and Cellular Therapy · 8
Total body irradiation (18 Gy) without chemotherapy as conditioning for allogeneic hematopoietic cell transplantation in refractory acute myeloid leukemia
2020 · Sultan Altouri, David Allan, et al. · Bone Marrow Transplantation · 7
Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective
2025 · Tana Saiyin, Grace Christou, et al. · Current Oncology · 5
PDF
Predictive Factors of Overall Survival and the Completion of Four Cycles of Azacitidine: An MDS-CAN Study
2017 · Danielle Blunt, Richard A. Wells, et al. · Blood · 3
Health Related Quality of Life Remains Stable over Time in Myelodysplastic Syndrome: An MDS-CAN Prospective Study
2018 · Danielle N. Blunt, Richard A. Wells, et al. · Blood · 2
Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia
2021 · Kelsey Uminski, Roy Khalife, et al. · Annals of Hematology · 1
Primary care for recipients of allogeneic hematopoietic stem cell transplantation
2020 · Jill Fulcher, Sherrie Hertz, et al. · Canadian Medical Association Journal · 1
PDF
Acute Myeloid Leukemia (AML) Treated with Azacitidine: Survival Outcomes for Patients Who Complete More Than Six Cycles Are Similar to High-Risk Myelodysplastic Syndrome/Low Blast Count AML
2019 · Jill Fulcher, Zahra Abdrabalamir Alshammasi, et al. · Blood · 1
Characteristics of Venous Thromboembolism in Patients with Acute Leukemia
2017 · Yuqi Wang, Nathan Cantor, et al. · Blood · 1
Grip strength is associated with overall survival in myelodysplastic syndrome
2026 · Nicholas L.J. Chornenki, Lee Mozessohn, et al. · Blood Advances
PDF
Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL
2025 · Daniela R. Anderson, Radhika Gangaraju, et al. · Blood Advances
PDF
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy
2024 · Daniela R Anderson, Radhika Gangaraju, et al. · Blood
PDF
Improving Healthcare Transition of Young Adults with Chronic Diseases at The Ottawa Hospital: a cross-sectional study assessing the patient’s perspective on current practices
2022 · Jill Fulcher, Janine Malcolm, et al. · Research Square
PDF
Soins primaires pour les bénéficiaires d’allogreffe de cellules souches hématopoïétiques
2021 · Jill Fulcher, Sherrie Hertz, et al. · Canadian Medical Association Journal
PDF
Single-Center 20-Year Experience of Matched Allogenic Hematopoietic Stem Cell Transplantation in Adults with T-ALL/Lbl Using Cyclophosphamide and Total Body Irradiation
2021 · Osman Radhwi, Ayel Yahya, et al. · Transplantation and Cellular Therapy
Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia
2020 · Jill Fulcher, Eugene Leung, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Intermediate Vs High Dose Busulfan-Based Conditioning for Allogeneic Cell Transplantation in Patients with Acute Leukemia or Myelodysplastic Syndromes from HLA Matched Related or Unrelated Donors: Achieving the Same with Less
2020 · Mohamad Sobh, Lothar Huebsch, et al. · Transplantation and Cellular Therapy
Works count: 28
Citation count: 167
H-index: 8
I10-index: 8
Year
Topic
Type